Thompson Siegel & Walmsley LLC Lannett CO Inc Transaction History

Thompson Siegel & Walmsley LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$1.56 - $2.93 $5,288 - $9,932	-3,390 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$8.49 - $12.81 $28,781 - $43,425	3,390 New	3,390 $30,000
Q2 2018 Aug 09, 2018	SELL	$13.3 - $17.45 $2,500 - $3,280	-188 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$14.7 - $24.95 $10.3 Million - $17.4 Million	-698,542 Reduced 99.97%	188 $3,000
Q4 2017 Feb 09, 2018	SELL	$19.9 - $29.25 $6.2 Million - $9.11 Million	-311,502 Reduced 30.83%	698,730 $16.2 Million
Q3 2017 Nov 08, 2017	BUY	$15.1 - $19.25 $2.59 Million - $3.31 Million	171,751 Added 20.48%	1,010,232 $18.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	838,481	838,481 $17.1 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.